| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $9,682,274 ) (Continued on the next page) |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 11219 | | USA | 02CH012426 | Head Start and Early Head Start | 00 | 1 | ACF | 12/14/2023 | $23,024 |
| | 2024 | 2024 | REDACTED DUE TO PII | | DAVIS | CA | 95618 | YOLO | USA | F31MH135696 | Optimizing in vivo dLight recordings for investigating the influence of disease on dopamine signaling. | 001 | 1 | NIH | 3/11/2024 | $0 |
| | 2024 | 2024 | REDACTED DUE TO PII | | MINNEAPOLIS | MN | 55455 | HENNEPIN | USA | F32DC021847 | Prosody perception in cochlear implant listeners | 002 | 1 | NIH | 4/25/2024 | $4,784 |
| | 2024 | 2024 | REDACTED DUE TO PII | | MINNEAPOLIS | MN | 55455 | HENNEPIN | USA | F32DC021847 | Prosody perception in cochlear implant listeners | 001 | 1 | NIH | 4/24/2024 | $0 |
| | 2024 | 2024 | REDACTED DUE TO PII | | MINNEAPOLIS | MN | 55455 | HENNEPIN | USA | F32DC021847 | Prosody perception in cochlear implant listeners | 000 | 1 | NIH | 12/1/2023 | $72,200 |
| | 2024 | 2024 | REDACTED DUE TO PII | | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | OT2OD031916 | Disability Community Engagement Partner Project | 001 | 1 | NIH | 6/28/2024 | $400,000 |
| | 2024 | 2024 | REDACTED DUE TO PII | | KADUNA STATE | | | | NGA | K43TW012015 | Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis | 000 | 4 | NIH | 5/21/2024 | $115,344 |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 68025 | | USA | 07CH012586 | Head Start and Early Head Start | 01 | 1 | ACF | 6/25/2024 | $23,053 |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 68025 | | USA | 07CH012586 | Head Start and Early Head Start | 00 | 1 | ACF | 4/29/2024 | $980,961 |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 68025 | | USA | 07CH012586 | Head Start and Early Head Start | 00 | 1 | ACF | 4/29/2024 | $4,500 |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 68025 | | USA | 07CH012586 | Head Start and Early Head Start | 00 | 1 | ACF | 4/29/2024 | $11,708 |
| | 2024 | 2024 | REDACTED DUE TO PII | | WASHINGTON | DC | 20036 | DISTRICT OF COLUMBIA | USA | OT2OD025277 | Todos Juntos: All of Us Research Program | 001 | 2 | NIH | 6/27/2024 | $2,000,000 |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 11219 | | USA | 02CH012426 | Head Start and Early Head Start | 01 | 1 | ACF | 4/5/2024 | $3,736,144 |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 11219 | | USA | 02CH012426 | Head Start and Early Head Start | 01 | 1 | ACF | 4/5/2024 | $23,023 |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 11219 | | USA | 02CH012426 | Head Start and Early Head Start | 01 | 1 | ACF | 4/5/2024 | $15,349 |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 11219 | | USA | 02CH012426 | Head Start and Early Head Start | 00 | 1 | ACF | 12/14/2023 | $3,736,145 |
| | 2024 | 2024 | REDACTED DUE TO PII | | DAVIS | CA | 95618 | YOLO | USA | F31MH135696 | Optimizing in vivo dLight recordings for investigating the influence of disease on dopamine signaling. | 000 | 1 | NIH | 3/11/2024 | $40,692 |
| | 2024 | 2024 | REDACTED DUE TO PII | | | | 11219 | | USA | 02CH012426 | Head Start and Early Head Start | 00 | 1 | ACF | 12/14/2023 | $15,349 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 20405 | | USA | 90SFGE0052 | Mixed-Methods Examination of the Experiences of Black and Latinx Parents of Autistic Children Working with Their Child's Therapists During the Early Intervention-to-Special Education Transition | 01 | 1 | ACL | 12/6/2023 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 20405 | | USA | 90SFGE0044 | Evaluating the relationships between hospital-based rehabilitation service delivery factors and community discharge, change in function, and readmission risk for older adults hospitalized for stroke | 01 | 1 | ACL | 12/6/2023 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 20405 | | USA | 90SFGE0047 | Augmented Reality Enhanced Supported Employment for Individuals with Intellectual and Developmental Disabilities | 01 | 1 | ACL | 12/6/2023 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 20405 | | USA | 90SFGE0051 | Evaluating readiness of caregivers following a loved one?s discharge home from inpatient rehabilitation: Validating the PATH-25 for the moderate-severe TBI population | 01 | 1 | ACL | 12/6/2023 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 20405 | | USA | 90SFGE0053 | Healthcare Provider Implicit Bias Training to Improve the Sexual and Reproductive Healthcare of Women with Disability | 01 | 1 | ACL | 12/6/2023 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 20405 | | USA | 90SFGE0045 | Investigate Novel Home Based Telerehabilitation Systems Integrated with Rehabilitation Robots to Rehabilitate Stroke Survivors with Upper Limb Dysfunctions. | 01 | 1 | ACL | 12/6/2023 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 20405 | | USA | 90SFGE0050 | Towards Improved Coordination and Personalization in Lower-Limb Prostheses: Auto-Tuning Embedded Gait-Phase-Based Impedance Control | 01 | 1 | ACL | 12/6/2023 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 20405 | | USA | 90SFGE0049 | Investigating Gabs in Self-management, Secondary Conditions, and Quality of Life among Aging Blacks with Spinal Cord Injury | 01 | 1 | ACL | 12/6/2023 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | TORONTO | ON | | | CAN | R21AG080575 | Discovery and validation of biomarkers of autoimmunity in Alzheimer's Disease. | 000 | 1 | NIH | 11/16/2023 | -$138,240 |
| | 2024 | 2023 | REDACTED DUE TO PII | | TORONTO | ON | | | CAN | R21AG080575 | Discovery and validation of biomarkers of autoimmunity in Alzheimer's Disease. | 001 | 1 | NIH | 11/21/2023 | $138,240 |
| | 2024 | 2023 | REDACTED DUE TO PII | | BLACKSBURG | VA | 24060 | MONTGOMERY | USA | R00NS117657 | Context-dependent neural processing of leg proprioception in Drosophila | 000 | 3 | NIH | 10/12/2023 | $151 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 96003 | | USA | NH28CE003078 | Shasta FNL In Action for DFC | 01 | 4 | CDC | 2/2/2024 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | LONDON | | | | GBR | F31AI167535 | Development and application of subnational measles incidence and mortality estimates in high burden and incidence settings | 000 | 2 | NIH | 5/23/2024 | -$17,667 |
| | 2024 | 2023 | REDACTED DUE TO PII | | WASHINGTON | DC | 20036 | DISTRICT OF COLUMBIA | USA | OT2OD025277 | Todos Juntos: All of Us Research Program | 000 | 2 | NIH | 6/18/2024 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | WASHINGTON | DC | 20036 | DISTRICT OF COLUMBIA | USA | OT2OD025277 | Todos Juntos: All of Us Research Program | 000 | 2 | NIH | 6/18/2024 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | WASHINGTON | DC | 20036 | DISTRICT OF COLUMBIA | USA | OT2OD025277 | Todos Juntos: All of Us Research Program | 000 | 2 | NIH | 6/18/2024 | $0 |
| | 2024 | 2023 | REDACTED DUE TO PII | | | | 20405 | | USA | 90SFGE0046 | Rural-urban disparities in post-acute therapy utilization: identifying hot spots of low utilization among fee-for-service Medicare beneficiaries toward informing policy and public health interventions | 01 | 1 | ACL | 12/6/2023 | $0 |
| | 2024 | 2022 | REDACTED DUE TO PII | | LONDON | | | | GBR | F32DA055459 | Examining Neural Modulatory Effects of Serotonergic Psychedelic Compounds in Relation to Neuroticism | 000 | 1 | NIH | 1/19/2024 | -$14,430 |
| | 2024 | 2022 | REDACTED DUE TO PII | | LONDON | | | | GBR | U01CA269143 | ARCHERY: Artificial Intelligence based Radiotherapy treatment planning for Cervical and Head and Neck cancer | 000 | 1 | NIH | 10/19/2023 | $0 |
| | 2024 | 2022 | REDACTED DUE TO PII | | | | 61605 | | USA | 05CH010613 | Head Start and Early Head Start | 05 | 5 | ACF | 5/14/2024 | -$960,020 |
| | 2024 | 2022 | REDACTED DUE TO PII | | | | 61605 | | USA | 05CH010613 | Head Start and Early Head Start | 05 | 5 | ACF | 5/14/2024 | -$5,443 |
| | 2024 | 2022 | REDACTED DUE TO PII | | | | 61605 | | USA | 05CH010613 | Head Start and Early Head Start | 05 | 5 | ACF | 5/14/2024 | -$10,891 |
| | 2024 | 2022 | REDACTED DUE TO PII | | DAVIS | CA | 95618 | YOLO | USA | F30CA232669 | SYCP3 Inactivates BRCA2 Increasing Risk of Genomic Instability: Misexpression of germ-line protein, SYCP3, in somatic cells causes BRCA2 functional deficiency increasing risk of genomic instability. | 001 | 4 | NIH | 3/22/2024 | -$2,500 |
| | 2024 | 2022 | REDACTED DUE TO PII | | SOLNA | | | | SWE | F31CA224806 | Redox modulation - Impact on Tumor Growth and Therapeutic Anticancer Efficacy | 001 | 4 | NIH | 1/30/2024 | $0 |
| | 2024 | 2022 | REDACTED DUE TO PII | | LOS ANGELES | CA | 90024 | LOS ANGELES | USA | K23MH113884 | Investigating Circadian Rhythms in Youth with Persistent Tic Disorders | 000 | 5 | NIH | 3/4/2024 | -$19,995 |
| | 2024 | 2022 | REDACTED DUE TO PII | | MONTREAL | QC | | | CAN | F32AG064810 | The behavioral and neurocognitive effects of bilingual experience on cognitive control and language processing: Implications for aging in two languages | 001 | 3 | NIH | 3/25/2024 | $0 |
| | 2024 | 2022 | REDACTED DUE TO PII | | LONDON | | | | GBR | F32DA055459 | Examining Neural Modulatory Effects of Serotonergic Psychedelic Compounds in Relation to Neuroticism | 001 | 1 | NIH | 5/22/2024 | -$9,165 |
| | 2024 | 2021 | REDACTED DUE TO PII | | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | OT2OD031916 | Disability Community Engagement Partner Project | 000 | 1 | NIH | 6/17/2024 | $0 |
| | 2024 | 2021 | REDACTED DUE TO PII | | | | 61605 | | USA | 05CH010613 | Head Start and Early Head Start | 03 | 4 | ACF | 6/29/2024 | $0 |
| | 2024 | 2021 | REDACTED DUE TO PII | | | | 61605 | | USA | 05CH010613 | Head Start and Early Head Start | 03 | 4 | ACF | 6/29/2024 | $0 |
| | 2024 | 2021 | REDACTED DUE TO PII | | | | 61605 | | USA | 05CH010613 | Head Start and Early Head Start | 03 | 4 | ACF | 6/29/2024 | $0 |
|
